Search All News
Dr. Jeffrey Lieberman and co-authors hypothesized that combining the xanomeline with trospium could lessen xanomeline's typical side effects in treating schizophrenia.
Columbia researchers have published their first report on mass shootings from the Columbia Mass Murder Database (CMMD).
- November 16, 2020
The Substance Abuse and Mental Health Services Administration has awarded $32 million to the American Academy of Addiction Psychiatry to address opioid use disorders and stimulant use disorders.
Source:BusinesswireNovember 16, 2020
“The COVID-19 pandemic will be accompanied by a wave of mental health consequences for children, adolescents, and families,” said Dr. Jeremy Veenstra-VanderWeele.
- November 9, 2020
Columbia researchers have found a potential neurobiological mechanism for hallucinations and delusions that fits within the hierarchical model of psychosis and can explain their clinical presentation
Source:MedscapeOctober 26, 2020
Dr. J. John Mann joins Dr. Lloyd Sederer on Medscape to discuss the effectiveness of Ketamine as a treatment for depression.
Source:Verywell MindSeptember 28, 2020
"For children not physically attending school, it is important to build and maintain other meaningful social opportunities," says Dr. Anthony Puliafico.
Source:StatSeptember 18, 2020
“I think intuitively all the people in this field know that the future of mental health is going to involve digital health care in some way, shape, or form,” said Dr. Ravi Shah.
- September 4, 2020
“I know there was a dip in experimental productivity initially, but in the last six weeks, I think we’re almost back to normal,” says Dr. David Sulzer.
- August 14, 2020
A study involving older adults with pre-existing major depressive disorder found no increase in depression and anxiety during the COVID-19 pandemic.